Newsbenzinga
Genmab's Encouraging Oncology Data Boosts Investor Optimism
· Published
Article summary
Genmab shares positive petosemtamab trial data across multiple solid tumors at ESMO and partners with Incyte on targeted colorectal therapy.
An excerpt from the original article.
Comments —
Loading comments…